ITI Pharma and Healthcare Fund - Direct Plan - IDCW Reinvestment vs Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth
NAV, returns and costs — not a recommendation.
 ITI Pharma and Healthcare Fund - Direct Plan - IDCW Reinvestment |  Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth | |
|---|---|---|
| NAV | ₹19.4606 | ₹17.282 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +13.87% | +24.16% |
| 3 year (p.a.) | +19.03% | +22.95% |
| 5 year (p.a.) | +14.59% | +22.95% |
| Expense ratio | 0.68% | 0.60% |
| Fund size | ₹237.99 Cr | ₹664.02 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.